March 03, 2017 09:18 ET
TORONTO, ONTARIO--(Marketwired - March 3, 2017) - Effective immediately the shares of Abattis Bioceuticals Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
Effective Date: March 3, 2017
Canadian Securities Exchange (CSE)Listings(416) 367-7340Listings@thecse.comwww.thecse.com
See all RSS Newsfeeds